Skip to main content

Animations

MJFF Publications

7281 - 7290 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2024
  • 2017
  • 2018
  • 2020
  • 2019
  • 2023
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368
    Citation Count: 23
  • Summary Details
    OPEN
    Title: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect
    Journal Name: Physical Biology
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1478-3975/abb6dc
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101251
    Citation Count: 0
  • Summary Details
    OPEN
    Title: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.13937
    Citation Count: 23
  • Summary Details
    OPEN
    Title: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00417
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Motor phenotype classification in moderate to advanced PD in BioFIND study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.017
    Citation Count: 23
  • Summary Details
    OPEN
    Title: New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissues
    Journal Name: Frontiers in Molecular Biosciences
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fmolb.2023.1087982
    Citation Count: 9
  • Summary Details
    OPEN
    Title: The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson’s Disease
    Journal Name: Aging, Neuropsychology, and Cognition
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/13825585.2019.1653445
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.006
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.